BMRN logo

BioMarin Pharmaceutical (BMRN) Total Liabilities

BMRN Annual Total Liabilities

$1.89 B
+$118.14 M+6.67%

31 December 2023

BMRN Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BMRN Quarterly Total Liabilities

$1.44 B
-$343.02 M-19.26%

30 September 2024

BMRN Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BMRN Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+6.7%-23.9%
3 y3 years+8.5%-19.0%
5 y5 years+29.5%-19.0%

BMRN Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+8.7%-23.9%at low
5 y5-yearat high+20.6%-31.7%at low
alltimeall timeat high>+9999.0%-31.7%>+9999.0%

BioMarin Pharmaceutical Total Liabilities History

DateAnnualQuarterly
Sept 2024
-
$1.44 B(-19.3%)
June 2024
-
$1.78 B(-1.0%)
Mar 2024
-
$1.80 B(-4.8%)
Dec 2023
$1.89 B(+6.7%)
$1.89 B(+1.5%)
Sept 2023
-
$1.86 B(+4.5%)
June 2023
-
$1.78 B(+0.3%)
Mar 2023
-
$1.77 B(+0.2%)
Dec 2022
$1.77 B(+1.9%)
$1.77 B(+4.5%)
Sept 2022
-
$1.70 B(+3.3%)
June 2022
-
$1.64 B(-1.8%)
Mar 2022
-
$1.67 B(-3.9%)
Dec 2021
$1.74 B(-0.2%)
$1.74 B(+1.6%)
Sept 2021
-
$1.71 B(+3.3%)
June 2021
-
$1.66 B(+0.8%)
Mar 2021
-
$1.64 B(-5.7%)
Dec 2020
$1.74 B(+11.1%)
$1.74 B(-17.2%)
Sept 2020
-
$2.10 B(+1.9%)
June 2020
-
$2.07 B(+39.3%)
Mar 2020
-
$1.48 B(-5.4%)
Dec 2019
$1.57 B(+7.4%)
$1.57 B(+5.7%)
Sept 2019
-
$1.48 B(+3.6%)
June 2019
-
$1.43 B(-4.4%)
Mar 2019
-
$1.50 B(+2.7%)
Dec 2018
$1.46 B(-20.0%)
$1.46 B(-18.0%)
Sept 2018
-
$1.78 B(+2.3%)
June 2018
-
$1.74 B(-2.8%)
Mar 2018
-
$1.79 B(-1.9%)
Dec 2017
$1.82 B(+45.1%)
$1.82 B(+3.2%)
Sept 2017
-
$1.77 B(+44.3%)
June 2017
-
$1.22 B(+4.7%)
Mar 2017
-
$1.17 B(-7.0%)
Dec 2016
$1.26 B(-5.4%)
$1.26 B(+5.1%)
Sept 2016
-
$1.20 B(+2.3%)
June 2016
-
$1.17 B(-15.0%)
Mar 2016
-
$1.38 B(+3.6%)
Dec 2015
$1.33 B(+40.2%)
$1.33 B(-0.3%)
Sept 2015
-
$1.33 B(+3.1%)
June 2015
-
$1.29 B(+4.7%)
Mar 2015
-
$1.23 B(+30.2%)
Dec 2014
$947.49 M(+4.9%)
$947.49 M(+1.7%)
Sept 2014
-
$931.99 M(+5.5%)
June 2014
-
$883.72 M(+0.4%)
Mar 2014
-
$880.61 M(-2.5%)
Dec 2013
$903.02 M(+63.4%)
$903.02 M(+162.5%)
Sept 2013
-
$344.04 M(+0.2%)
June 2013
-
$343.26 M(-1.4%)
Mar 2013
-
$348.14 M(-37.0%)
Dec 2012
$552.58 M(+3.7%)
$552.58 M(+0.1%)
Sept 2012
-
$552.18 M(+3.8%)
June 2012
-
$532.10 M(+1.3%)
Mar 2012
-
$525.13 M(-1.4%)
Dec 2011
$532.66 M
$532.66 M(+2.3%)
DateAnnualQuarterly
Sept 2011
-
$520.54 M(-5.0%)
June 2011
-
$548.09 M(+0.9%)
Mar 2011
-
$543.31 M(-0.4%)
Dec 2010
$545.37 M(-8.3%)
$545.37 M(-17.2%)
Sept 2010
-
$658.87 M(+5.8%)
June 2010
-
$622.55 M(+0.3%)
Mar 2010
-
$620.97 M(+4.4%)
Dec 2009
$594.98 M(-5.6%)
$594.98 M(+5.2%)
Sept 2009
-
$565.50 M(+0.8%)
June 2009
-
$561.00 M(-10.4%)
Mar 2009
-
$626.34 M(-0.6%)
Dec 2008
$630.02 M(+0.4%)
$630.02 M(+1.4%)
Sept 2008
-
$621.14 M(-1.2%)
June 2008
-
$628.53 M(+1.6%)
Mar 2008
-
$618.54 M(-1.4%)
Dec 2007
$627.55 M(+81.6%)
$627.55 M(+1.8%)
Sept 2007
-
$616.51 M(+0.4%)
June 2007
-
$614.04 M(+115.4%)
Mar 2007
-
$285.05 M(-17.5%)
Dec 2006
$345.63 M(+26.7%)
$345.63 M(+0.2%)
Sept 2006
-
$344.95 M(-17.8%)
June 2006
-
$419.83 M(-5.1%)
Mar 2006
-
$442.22 M(+62.1%)
Dec 2005
$272.76 M(-9.4%)
$272.76 M(-0.5%)
Sept 2005
-
$274.22 M(-1.2%)
June 2005
-
$277.69 M(+2.4%)
Mar 2005
-
$271.17 M(-9.9%)
Dec 2004
$300.94 M(+117.3%)
$300.94 M(+1.0%)
Sept 2004
-
$298.07 M(-2.0%)
June 2004
-
$304.23 M(+116.5%)
Mar 2004
-
$140.52 M(+1.5%)
Dec 2003
$138.49 M(+1047.1%)
$138.49 M(-2.8%)
Sept 2003
-
$142.48 M(-1.0%)
June 2003
-
$143.95 M(+736.2%)
Mar 2003
-
$17.21 M(+42.6%)
Dec 2002
$12.07 M(-1.5%)
$12.07 M(+7.2%)
Sept 2002
-
$11.26 M(+0.6%)
June 2002
-
$11.19 M(-13.5%)
Mar 2002
-
$12.94 M(+5.5%)
Dec 2001
$12.26 M(+76.7%)
$12.26 M(+96.6%)
Sept 2001
-
$6.24 M(+17.2%)
June 2001
-
$5.32 M(+44.4%)
Mar 2001
-
$3.68 M(-46.9%)
Dec 2000
$6.94 M(+34.2%)
$6.94 M(+89.0%)
Sept 2000
-
$3.67 M(+26.9%)
June 2000
-
$2.89 M(-39.2%)
Mar 2000
-
$4.76 M(-8.0%)
Dec 1999
$5.17 M(+145.1%)
$5.17 M(-9.3%)
Sept 1999
-
$5.70 M(-83.2%)
June 1999
-
$34.00 M(+1900.0%)
Mar 1999
-
$1.70 M
Dec 1998
$2.11 M
-

FAQ

  • What is BioMarin Pharmaceutical annual total liabilities?
  • What is the all time high annual total liabilities for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical annual total liabilities year-on-year change?
  • What is BioMarin Pharmaceutical quarterly total liabilities?
  • What is the all time high quarterly total liabilities for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical quarterly total liabilities year-on-year change?

What is BioMarin Pharmaceutical annual total liabilities?

The current annual total liabilities of BMRN is $1.89 B

What is the all time high annual total liabilities for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high annual total liabilities is $1.89 B

What is BioMarin Pharmaceutical annual total liabilities year-on-year change?

Over the past year, BMRN annual total liabilities has changed by +$118.14 M (+6.67%)

What is BioMarin Pharmaceutical quarterly total liabilities?

The current quarterly total liabilities of BMRN is $1.44 B

What is the all time high quarterly total liabilities for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high quarterly total liabilities is $2.10 B

What is BioMarin Pharmaceutical quarterly total liabilities year-on-year change?

Over the past year, BMRN quarterly total liabilities has changed by -$452.25 M (-23.93%)